Oncolytics Biotech buy Canaccord Genuity Group Inc.
Start price
06.03.23
/
50%
€1.61
Target price
06.03.24
€4.69
Performance (%)
-
End price
07.03.24
-
Summary
This prediction was cancelled by the user.Performance without dividends (%)
Name | 1w | 1m | 1y |
---|---|---|---|
Oncolytics Biotech | - | - | - |
iShares Core DAX® | 2.291% | 2.984% | 20.344% |
iShares Nasdaq 100 | 1.336% | -0.196% | 25.550% |
iShares Nikkei 225® | 1.132% | 2.488% | 13.163% |
iShares S&P 500 | 1.272% | 1.334% | 24.544% |
Comments by Canaccord_Genuity_Gr for this prediction
In the thread Oncolytics Biotech diskutieren
Oncolytics Biotech Inc. (NASDAQ: ONCY) had its price target lowered by analysts at Canaccord Genuity Group Inc. from $6.00 to $5.00. They now have a "buy" rating on the stock.
Ratings data for ONCY provided by MarketBeat
In the thread Trading Oncolytics Biotech
Die von Canaccord_Genuity_Gr gewählte maximale Laufzeit wurde überschritten